scholarly article | Q13442814 |
P50 | author | Alicia Jenkins | Q63481321 |
David O'Neal | Q87947749 | ||
Emma S Scott | Q92334102 | ||
P2093 | author name string | Anandwardhan A Hardikar | |
Rachel T McGrath | |||
Andrzej S Januszewski | |||
Gregory Fulcher | |||
Daniel Calandro | |||
P2860 | cites work | Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus | Q24240609 |
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes | Q30274891 | ||
Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home | Q30276766 | ||
A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial | Q31164826 | ||
Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial | Q33873080 | ||
HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes | Q34546548 | ||
A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes | Q34718250 | ||
HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patients | Q35114974 | ||
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study | Q35765550 | ||
Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality | Q35981134 | ||
Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes | Q36297813 | ||
Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study | Q36417410 | ||
Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study | Q37280510 | ||
A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes | Q37400773 | ||
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia | Q38265052 | ||
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. | Q38381848 | ||
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial | Q38381853 | ||
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis. | Q38647077 | ||
Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes. | Q39760755 | ||
Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction | Q40353553 | ||
High hemoglobin A1c variability is associated with early risk of microalbuminuria in children with T1D. | Q40531970 | ||
Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study | Q41431685 | ||
Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control | Q43052147 | ||
Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes | Q43441184 | ||
Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure. | Q44869345 | ||
International Consensus on Use of Continuous Glucose Monitoring. | Q45073594 | ||
A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. | Q46149736 | ||
Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes | Q46667179 | ||
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients | Q46734168 | ||
A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial | Q47387128 | ||
Metabolic control and its variability are major risk factors for microalbuminuria in children with type 1 diabetes | Q48866435 | ||
Vascular function and glucose variability improve transiently following initiation of continuous subcutaneous insulin infusion in children with type 1 diabetes | Q49168090 | ||
Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. | Q51246622 | ||
Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study. | Q51713216 | ||
Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study | Q88412797 | ||
Short-term glucose variability in adults with Type 1 diabetes does not differ between insulin pump and multiple daily injection users - a masked continuous glucose monitoring study in clinical practice | Q89224061 | ||
Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study | Q90465934 | ||
P433 | issue | 12 | |
P921 | main subject | type-1 diabetes | Q124407 |
P304 | page(s) | e033059 | |
P577 | publication date | 2019-12-29 | |
P1433 | published in | BMJ Open | Q17003470 |
P1476 | title | HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment | |
P478 | volume | 9 |
Search more.